Sunday, June 28, 2026
ADVT 
National

COVID-19 cases rise for the 5th week, deaths stable

Darpan News Desk The Canadian Press, 14 Jul, 2022 03:04 PM
  • COVID-19 cases rise for the 5th week, deaths stable

GENEVA (AP) — The number of new coronavirus cases reported worldwide rose for the fifth week in a row while the number of deaths remained relatively stable, the World Health Organization reported Thursday.

In the U.N. health agency’s weekly review of the COVID-19 pandemic, WHO said there were 5.7 million new infections confirmed last week, marking a 6% increase. There were 9.800 deaths, roughly similar to the previous week’s figure.

Earlier this week, WHO Director-General Tedros Adhanom Ghebreyesus said the pandemic still qualifies as a global emergency and he was “concerned” about the recent spike.

“The virus is running freely, and countries are not effectively managing the disease burden,” he said during a Tuesday press briefing. “New waves of the virus demonstrate again that COVID-19 is nowhere near over.”

In the last two weeks, cases of COVID-19 reported to WHO surged 30%, driven largely by the hugely infectious omicron relatives, BA.4 and BA.5. The two omicron subvariants have shown a worrisome ability to re-infect people previously vaccinated or who have recovered from COVID.

According to WHO, the biggest increases in COVID-19 cases were seen in the Western Pacific and the Middle East, where they jumped by more than a quarter. Deaths spiked by 78% in the Middle East and by 23% in Southeast Asia, while dropping elsewhere or remaining stable.

WHO said that relaxed COVID-19 surveillance and testing programs in numerous countries have complicated efforts to track the virus and to catch any potentially dangerous new variants.

In the U.S. , the new omicron variants have pushed up hospitalizations and deaths in recent weeks, prompting some cities and states to rethink their approaches. White House COVID-19 coordinator Dr. Ashish Jha, during a Wednesday TV appearance, called for booster shots and renewed vigilance against the virus.

The White House response team has also urged all adults 50 and older to urgently get a booster if they haven’t yet this year — and dissuaded people from waiting for the next generation of shots expected in the fall.

MORE National ARTICLES

Police group pushes back on B.C. roadblocks

Police group pushes back on B.C. roadblocks
Mike Farnworth described the checkpoints as a type of "counterattack," often used to find drunk drivers, but this time meant to discourage recreational travel outside of a person's health authority.

Police group pushes back on B.C. roadblocks

Meng gets OK to delay final hearings

Meng gets OK to delay final hearings
The hearings were scheduled to begin Monday but Meng's lawyers said they needed more time to review documents related to the case obtained through a Hong Kong court.

Meng gets OK to delay final hearings

Goodale appointed Canada's new commissioner in UK

Goodale appointed Canada's new commissioner in UK
Goodale will advise Trudeau on how the two countries should work together to beat the COVID-19 pandemic, fight climate change, pursue post-Brexit trade and build back after the pandemic.

Goodale appointed Canada's new commissioner in UK

ICU pressures mount as COVID fells younger people

ICU pressures mount as COVID fells younger people
British Columbia, Alberta, Manitoba and Ontario have been giving AstraZeneca to people as young as 40 and in Quebec as young as 45.

ICU pressures mount as COVID fells younger people

Freeland urges patience on reopening border

Freeland urges patience on reopening border
Public Safety Minister Bill Blair on Tuesday extended restrictions on non-essential travel from overseas and across the border with the U.S. for another month.

Freeland urges patience on reopening border

National AstraZeneca advice delayed by new data

National AstraZeneca advice delayed by new data
NACI was minutes away Tuesday afternoon from providing an update to its advice that AstraZeneca shouldn't be given to people under the age of 55 but the planned briefing was called off.

National AstraZeneca advice delayed by new data